Viewing nowJW Donapezil Orally Disintegrating Tablets 10 mg
Donepezil Hydrochloride Hydrate 10.43mg
Orally disintegrating Tablet · Prescription medication
JW Pharmaceutical Corp.

MFDS item code 201002402 · Notified 2010.03.31 · Insurance code 644913040
Treatment of symptoms of Alzheimer-type dementia
This medicine is used to treat symptoms of Alzheimer's type dementia. It helps improve memory decline, cognitive dysfunction, and enhance daily living skills. Consistent use can help slow the progression of symptoms and maintain the quality of life.
○ Adults : Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this drug may be considered. Since donepezil concentrations reach steady state 15 days after administration and the frequency of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After evaluating the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with caution for gastrointestinal adverse reactions. The maximum dose of this drug is 10 mg. When this drug is discontinued, its effects gradually diminish, and no rebound effect occurs with abrupt discontinuation. This drug is an orally disintegrating tablet. Place it on the tongue and allow it to dissolve, then take with or without water (applicable to orally disintegrating tablets only). ○ Female patients aged 85 years or older who are underweight : Close monitoring is required because adverse reactions occur more frequently. Underweight elderly women should not receive more than 5 mg daily.
○ Children : There is no experience with use in children.
This medicine contains the ingredient Donepezil Hydrochloride and is primarily used to treat symptoms of Alzheimer's type dementia. This medicine should not be administered to individuals who are allergic to Donepezil Hydrochloride, piperidine derivatives, or any other components of this medicine. It is safest to avoid using this medicine during pregnancy or in women who may become pregnant, as well as in breastfeeding women. Patients with cardiac diseases, especially those with bradycardia or heart conduction disorders, should use this medicine with caution, as it may lead to bradycardia or arrhythmia. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should be cautious, as increased gastric acid secretion and enhanced gastrointestinal motility may exacerbate ulcers. Patients with asthma or obstructive pulmonary diseases may experience worsening symptoms due to bronchoconstriction and increased mucus secretion, thus careful monitoring is necessary. Patients with extrapyramidal disorders such as Parkinson's disease should use this medicine cautiously due to its cholinergic effects, which may worsen their symptoms. During treatment, there may be heart-related adverse reactions such as syncope, bradycardia, heart block, or QT interval prolongation; immediate consultation with a healthcare professional is necessary if these symptoms occur. Gastrointestinal adverse reactions including peptic ulcers, gastrointestinal bleeding, nausea, vomiting, and diarrhea may occur, so gastrointestinal symptoms should be carefully observed. Liver dysfunction or hepatitis symptoms may appear, and neurological adverse reactions such as seizures or cerebrovascular disorders have also been reported. Musculoskeletal adverse symptoms such as myalgia, muscle spasms, and rhabdomyolysis may occur, so muscle condition should be closely monitored. This medicine may affect driving ability or operating machinery; therefore, caution is necessary, especially at the start of treatment or when increasing the dosage. When combined with other medications, this medicine may affect metabolism or heart rhythm, so it is essential to inform healthcare providers about all medications being taken. During pregnancy, its safety has not been established, so it should not be used unless absolutely necessary, and breastfeeding women should either discontinue breastfeeding or avoid using this medicine. Safety in pediatric patients has not been established, so it is not administered to children. In case of an overdose, severe symptoms such as nausea, vomiting, bradycardia, hypotension, or respiratory depression may occur, necessitating immediate medical attention; atropine may be used as an antidote. This medicine should be taken as an orally disintegrating tablet by placing it on the tongue, allowing it to dissolve, and then swallowed with saliva or water, as it is not absorbed through the oral mucosa. Store this medicine in a tightly sealed container to prevent air and moisture ingress, and it is recommended to keep it at a temperature between 1°C and 30°C at room temperature. Proper storage will help maintain the effectiveness of the medicine.
Not everyone experiences these, and they can vary from person to person.
Store this medicine in a tightly sealed container to prevent air and moisture ingress, and it is recommended to keep it at a temperature between 1°C and 30°C at room temperature. This way, the effectiveness of the medicine can be well maintained.
Yellow round orally disintegrating tablet
30 tablets (10 tablets/alu-alu X 3 packs)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Orally disintegrating Tablet · Prescription medication
JW Pharmaceutical Corp.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.